Baker Brothers Advisors - BIODELIVERY SCIENCES INTL IN ownership

BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 67 filers reported holding BIODELIVERY SCIENCES INTL IN in Q2 2013. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of BIODELIVERY SCIENCES INTL IN
ValueSharesWeighting
Q1 2020$6,209,000
+901.5%
1,638,334
+680.1%
0.04%
+660.0%
Q2 2018$620,000
+31.1%
210,0210.0%0.01%
+25.0%
Q1 2018$473,000
-23.7%
210,0210.0%0.00%
-20.0%
Q4 2017$620,0000.0%210,0210.0%0.01%0.0%
Q3 2017$620,000
+5.4%
210,0210.0%0.01%0.0%
Q2 2017$588,000
+47.4%
210,0210.0%0.01%
+66.7%
Q1 2017$399,000
+8.4%
210,0210.0%0.00%
-25.0%
Q4 2016$368,000
-35.1%
210,0210.0%0.00%
-20.0%
Q3 2016$567,000
+14.3%
210,0210.0%0.01%0.0%
Q2 2016$496,000
-26.8%
210,0210.0%0.01%
-28.6%
Q1 2016$678,000
-32.6%
210,0210.0%0.01%
-12.5%
Q4 2015$1,006,000
-13.9%
210,0210.0%0.01%
-27.3%
Q3 2015$1,168,000
-30.1%
210,0210.0%0.01%
-26.7%
Q2 2015$1,672,000
-37.8%
210,021
-17.9%
0.02%
-31.8%
Q1 2015$2,686,000
+6.4%
255,866
+21.8%
0.02%
-15.4%
Q4 2014$2,524,000
-29.7%
210,0210.0%0.03%
-42.2%
Q3 2014$3,589,000
-29.4%
210,021
-50.1%
0.04%
-27.4%
Q2 2014$5,082,000
+43.0%
421,0050.0%0.06%
+37.8%
Q1 2014$3,553,000
-28.7%
421,005
-50.2%
0.04%
-35.7%
Q4 2013$4,983,000
+8.5%
846,0050.0%0.07%
+7.7%
Q3 2013$4,594,000
+25.7%
846,005
-6.1%
0.06%
-9.7%
Q2 2013$3,656,000900,5050.07%
Other shareholders
BIODELIVERY SCIENCES INTL IN shareholders Q2 2013
NameSharesValueWeighting ↓
Invenomic Capital Management LP 1,188,759$3,685,0000.79%
SYSTEMATIC FINANCIAL MANAGEMENT LP 4,339,837$13,453,0000.40%
EMC Capital Management 208,733$647,0000.35%
Rubric Capital Management LP 1,747,401$5,417,0000.26%
Zebra Capital Management LLC 50,887$158,0000.25%
Hillsdale Investment Management Inc. 1,184,300$3,672,0000.25%
WEALTH EFFECTS LLC 100,300$311,0000.13%
SHEPHERD KAPLAN KROCHUK, LLC 114,000$353,0000.13%
Manteio Capital LLC 23,879$74,0000.10%
GLOBEFLEX CAPITAL L P 273,162$846,0000.09%
View complete list of BIODELIVERY SCIENCES INTL IN shareholders